We were honoured to be invited to the Houses of Parliament for the Life Sciences & Innovation Showcase yesterday. It was a powerful reminder of what’s possible when relentless innovators unite to tackle great challenges. We left inspired, energised and proud of our part in this ecosystem. Thank you to Venturefest Oxford and the Oxford Trust for supporting the Oxfordshire ecosystem.
WE WON!!! Newrotex are absolutely delighted to have been awarded the MedTech Innovator Impact Award at MedTech Strategist Innovation Summit this week. We talk all the time about the impact of living with nerve injuries. The average patient suffering from peripheral nerve injury is just 32 years old. For patients with large-gap peripheral nerve injuries, today’s options often fall short — leaving many facing lifelong disability, loss of function, and a limited quality of life. Our goal with SilkAxons is to change that.
We’re pleased to share an early update from our first-in-human clinical trial of SilkAxons. The first cohort of patients has now reached the 6-month primary outcome milestone. To date, we have observed no adverse events, and all treated patients have already demonstrated meaningful functional recovery! Importantly, these cases all involved very large peripheral nerve gaps (8–10 cm) — injuries that remain highly challenging to treat with existing standards of care. Seeing effective recovery across this initial group is an encouraging early signal. While these results are preliminary and the study remains ongoing, crossing this milestone safely and successfully represents an important step forward for our program. We remain focused on disciplined clinical execution, rigorous follow-up, and transparent reporting as additional patients reach key endpoints We want to thank the patients, the team at the Panama Clinic and our CRO partners who have made this progress possible. We look forward to sharing further updates as the trial advances.
We had the pleasure of welcoming the BBC News team to our lab at the Wood Centre for Innovation last week to hear all about our pioneering research. Thank you to Jamie Morris for his fantastic article which you can read here https://www.bbc.co.uk/news/articles/ckgngvr2ye1o
New Chapter, New Home! 🎉 We are thrilled to announce that Newrotex has officially relocated to the Wood Centre for Innovation! This strategic relocation gives us the essential space needed to fuel our ambitious growth plans for 2026 and beyond. Crucially, this includes: 🏭Expanded Manufacturing: Increasing our capacity to deliver. 👫Team Growth: Welcoming more talent to our team. 🕷️Spider Colony: Providing a state-of-the-art home for our most unique collaborators! This new location is the foundation we need to turn our ambitious plans into reality. A massive, heartfelt thank you to our incredible team for working non-stop to get us moved and set up. Here is to an exciting 2026! A huge thank you to the Oxford Trust for being so welcoming and supporting us in this next transformational phase.
WORLD-FIRST ACHIEVED: Today has been an emotional day for the Newrotex Team as our first product SilkAxons was successfully implanted into a patient to repair their large nerve gap (10cm)! For patients with large-gap peripheral nerve injuries, today’s options often fall short — leaving many facing lifelong disability, loss of function, and a limited quality of life. Our goal with SilkAxons is to change that. This trial represents an important step toward offering a new treatment designed to restore function and independence for people who currently have few effective options. While it’s early days, this first enrollment is a milestone that brings us closer to making a real difference for patients and their families. Alex, our CEO says “As a previous Zoologist turned Trauma & Orthopaedic surgeon, I was first struck by the challenges of treating patients with nerve injuries during my early surgical training. Years later through research and collaborations we ultimately founded Newrotex with a vision to create something better for those patients. And it’s been a rollercoaster of the highs and lows of innovation – but always with the belief that we could make a difference. Today that belief became real”. We want to congratulate Dr Ricard Bermudez and his fantastic team at the Panama Clinic for achieving this Word First implantation bridging a gap larger than anything on the market can currently achieve. We are deeply grateful to the clinicians, trial teams, and most of all the patients who make this progress possible. As we continue this journey, we’re also mindful that addressing this profound unmet need represents not only an opportunity to change lives but also to build the foundation for a new standard of care in nerve repair — one with significant clinical and market impact.
At Newrotex, patients are at the heart of everything we do. Every day, countless individuals suffer life-changing nerve injuries — whether from trauma or as a complication of surgeries, such as those for breast or prostate cancer. Yet, the current gold-standard treatment still involves sacrificing healthy donor nerves from elsewhere in the body — a painful and invasive procedure with significant complications. This needs to change. Helen, pictured here, knows this reality all too well. She survived a devastating car accident that left her with multiple fractures and internal injuries. Despite the severity of her trauma — affecting her head, spine, ribs, and more — Helen says that the nerve injury to her arm was always her “biggest challenge”. As part of her extensive expert treatment at Oxford University Hospitals NHS Foundation Trust, Helen underwent a donor nerve graft procedure, where a nerve was taken from her leg in an effort to restore function in her arm. Since then Helen has been a powerful advocate for change, generously supporting Newrotex and our mission to transform how nerve injuries are treated. This behind-the-scenes image is from the filming our website and YouTube video, to tell people about what we do. Check them out to hear more from Helen as she shares her journey. Watch her story here: https://lnkd.in/eA8c-hMV We are so grateful to have the support of the public and patients like Helen who support the company by helping to share their experience of nerve injury, and help us to guide and develop our products to ensure that we are bringing something to market that will make a difference to patients as the priority. Together, we are working to create safer, more effective treatments that will empower both patients and surgeons with better choices. Thank you Helen!
Newrotex are delighted to announce that we are ISO 13485 certified! In the medical device industry, innovation is only half the battle. It is critical to build business processes and structure which ensure your business is consistently and reliably creating products which are safe, reliable, and compliant. What Is ISO 13485? At its core, ISO 13485 is the internationally recognized quality management standard specific to the medical device industry. ISO 13485 places a laser focus on: Risk management: Identifying and mitigating potential risks across the entire product lifecycle. Regulatory compliance: Aligning processes with global regulatory frameworks. Traceability: Ensuring every raw material, component, and manufacturing step can be audited and tracked. Controlled design & development: Verifying and validating products before they ever reach a patient or healthcare setting. Patient Safety Above All Else ISO 13485 forces us to design safety and risk controls directly into our processes rather than treating quality control as an afterthought. For our customers, this means total peace of mind knowing that every device leaving our facility meets rigid safety benchmarks. Consistency You Can Count On A great prototype is easy to build once. Replicating that exact level of precision across thousands of units—day in and day out—requires a world-class Quality Management System. By standardizing our workflows, supplier management, and production testing under ISO 13485, we have guaranteed batch-to-batch consistency so customers will receive the same high-performing product, every single time. A Passport to Global Markets Medical device regulations vary wildly from country to country. However, ISO 13485 acts as a universal language. It harmonizes regulatory requirements across international borders, allowing us to seamlessly expand our reach and supply critical devices to healthcare providers worldwide without administrative bottlenecks. Continuous Improvement Culture Achieving certification isn’t a one-and-done event; it’s an ongoing commitment to quality. What’s Next? Earning ISO 13485 certification reflects months of dedicated teamwork, process optimization, and a shared dedication to excellence. But more than that, it underscores our core promise: to deliver safe, effective, and reliable medical devices that healthcare providers can trust. We want to thank our incredible team for their continuous hard work.
Peripheral nerve injury remains one of the most underserved and overlooked challenges in trauma and reconstructive surgery. The Global Nerve Foundation plays a critical role in changing that—bringing together surgeons, researchers, patients, industry leaders and innovators to accelerate education, awareness and access to better nerve care globally. At Newrotex, our mission is to transform outcomes for patients suffering severe, long-gap peripheral nerve injuries through our off-the-shelf silk technology. Partnering with the Global Nerve Foundation strengthens our commitment to: 🔹 Collaborating with global KOLs in nerve surgery and peripheral nerve science 🔹 Contributing to education and innovation in a field that urgently needs new solutions 🔹 Building strategic connections across clinical, surgical, and industry communities 🔹 Accelerating the path toward better functional recovery for patients worldwide We’re excited to work alongside the Foundation and its partners to help advance the future of nerve repair.
